SenoMark® UltraCor® Breast Tissue Marker SMUC13CRecalls & reported problems

Bard Peripheral Vascular, Inc. · SenoMark® UltraCor® 14G x 13CM Coil · Class 2 · Implant

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports: 1
Deaths reported: 0
Injuries reported: 0
Recalls naming it: 0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 00801741032349), received between May 9, 2025 and May 9, 2025 — classified as 1 malfunction.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Reports received per month

Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

Adverse Event Without Identified Device or Use Problem1

Patient problems

No Clinical Signs, Symptoms or Conditions1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

MalfunctionMay 9, 2025Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
IT WAS REPORTED THAT APPROXIMATELY ONE MONTH POST A BREAST TISSUE MARKER PLACEMENT, THE PATIENT EXPERIENCED A RASH. THERE WAS NO REPORTED PATIENT INJURY.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 21991671 ↗

Device details

UDI-DI	`00801741032349`
Brand	SenoMark® UltraCor® Breast Tissue Marker
Model	SMUC13C
Company	Bard Peripheral Vascular, Inc.
Product code	NEU · MARKER, RADIOGRAPHIC, IMPLANTABLE
Class	Class 2
FDA submission	K123911
Implant	Yes
Rx / OTC	Prescription
Single use	Yes
Sterile	Yes
MRI safety	MR Conditional
Status	In Commercial Distribution
Record updated	Sep 18, 2023

Device type (GMDN): Radiological image marker, implantable

A device intended to be implanted within the body, either temporarily or permanently, to create identifying marks that can be seen on radiographic film or digital images. It is typically in the form of a wire, needle, bead, clip, stent-like tube, washer or fluid, and used to locate and delineate a tumour, lesion, or other site of interest. It is made from materials compatible with the imaging system with which it is intended to be used [e.g., magnetic resonance imaging (MRI), x-ray, or nuclear medicine]; it may be intended for use during radiotherapy procedures.

Other MARKER, RADIOGRAPHIC, IMPLANTABLE devices

BioZorb F0202
Hologic, Inc. · MARKER, RADIOGRAPHIC, IMPLANTABLE
2 recalls192 reports
BioZorb F0221
Hologic, Inc. · MARKER, RADIOGRAPHIC, IMPLANTABLE
3 recalls15 reports
BioZorb F0203
Hologic, Inc. · MARKER, RADIOGRAPHIC, IMPLANTABLE
2 recalls51 reports
BioZorb F0231
Hologic, Inc. · MARKER, RADIOGRAPHIC, IMPLANTABLE
2 recalls19 reports
BioZorb F0303
Hologic, Inc. · MARKER, RADIOGRAPHIC, IMPLANTABLE
2 recalls19 reports
BioZorb F0304
Hologic, Inc. · MARKER, RADIOGRAPHIC, IMPLANTABLE
2 recalls19 reports
BioZorb F0404
Hologic, Inc. · MARKER, RADIOGRAPHIC, IMPLANTABLE
2 recalls6 reports
BioZorb F0331
Hologic, Inc. · MARKER, RADIOGRAPHIC, IMPLANTABLE
2 recalls4 reports

All MARKER, RADIOGRAPHIC, IMPLANTABLE devices →

Sources and updates

Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.

How reports and recalls are matched · Editorial policy · Report an error on this page